Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-08

Clinical Trial Update: Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the food effect and dosage form proportionality of eslicarbazepine acetate has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2015-01-08